Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
about
Multi-disciplinary antimicrobial strategies for improving orthopaedic implants to prevent prosthetic joint infections in hip and kneeWill there ever be a universal Staphylococcus aureus vaccine?Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections.Rapid Identification of Vancomycin Resistant Enterococcus Faecalis Clinical Isolates using a Sugar Fermentation Method.Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.RNA-Seq Analysis of the Host Response to Staphylococcus aureus Skin and Soft Tissue Infection in a Mouse Model.Tissue-specific patterning of host innate immune responses by Staphylococcus aureus α-toxin.Animal Models of Implant-Related Low-Grade Infections. A Twenty-Year Review.Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.α-Toxin Regulates Local Granulocyte Expansion from Hematopoietic Stem and Progenitor Cells in Staphylococcus aureus-Infected Wounds.Evaluation of Antibiotics Active against Methicillin-Resistant Staphylococcus aureus Based on Activity in an Established BiofilmRapid Detection of Methicillin-Resistant Staphylococcus aureus Isolates by Turanose Fermentation Method.Neutralizing α-toxin accelerates healing of Staphylococcus aureus-infected wounds in normal and diabetic mice.Comparison of the immune response during acute and chronic Staphylococcus aureus infection.Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development.
P2860
Q26785872-FC5EAA8E-35D7-41FD-8D3E-CE873DB1CC11Q26824837-C8936376-1EDF-4218-8CCE-BE97AB278A16Q33601802-E32694FF-0AD3-4084-BE1F-2443C5F49734Q33666289-C1BDC6E1-3DE3-4D6B-8EAB-DDD618008033Q35031839-A094A327-2709-42EC-AF90-54DE000D9017Q35526164-243960E3-A5FF-4DE6-8CB6-EEAC7CD7A534Q35730332-60F26761-D1DA-474C-9339-AFDEA54AE533Q38975591-32E2CD11-6469-4837-96FB-9575CEEFFB20Q39185482-DE5E538E-5B3B-438F-86B7-F71756D2154EQ40124323-A395C54E-F9B2-48D0-91C3-1A53733F3777Q40617957-D580E140-6EB4-492B-996A-41561D043209Q40939791-AAD82FDD-967D-43A4-BD11-89DF624D8A98Q47193259-69BA63F2-C48C-4B06-BCCC-5F9605BA1230Q54245850-7DC7592C-F398-4BBC-80B6-EEC43C34468DQ55246404-0C917275-D9BF-4E31-B5D2-3B647265C975
P2860
Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Evaluation of genetically inac ...... aphylococcus aureus infection.
@ast
Evaluation of genetically inac ...... aphylococcus aureus infection.
@en
Evaluation of genetically inac ...... aphylococcus aureus infection.
@nl
type
label
Evaluation of genetically inac ...... aphylococcus aureus infection.
@ast
Evaluation of genetically inac ...... aphylococcus aureus infection.
@en
Evaluation of genetically inac ...... aphylococcus aureus infection.
@nl
prefLabel
Evaluation of genetically inac ...... aphylococcus aureus infection.
@ast
Evaluation of genetically inac ...... aphylococcus aureus infection.
@en
Evaluation of genetically inac ...... aphylococcus aureus infection.
@nl
P2093
P2860
P1433
P1476
Evaluation of genetically inac ...... aphylococcus aureus infection.
@en
P2093
Christopher P Mocca
Drusilla L Burns
Mark E Shirtliff
Ranjani Prabhakara
Rebecca A Brady
Roger D Plaut
Tod J Merkel
P2860
P304
P356
10.1371/JOURNAL.PONE.0063040
P407
P577
2013-04-29T00:00:00Z